Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
312 studies found for:    Open Studies | "Uterine Neoplasms"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting MRI and Metabolomics Biomarkers for Uterine Malignancy
Condition: Uterine Neoplasms
Intervention:
2 Recruiting Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix
Conditions: Uterine Cancer;   Cervical Cancer
Intervention: Radiation: Proton radiation therapy
3 Recruiting The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection
Condition: Uterine Cancer
Interventions: Drug: Dexmedetomidine group;   Drug: Control group
4 Recruiting Targeted Silica Nanoparticles for Image-Guided Intraoperative Sentinel Lymph Node Mapping in Head and Neck Melanoma, Breast and Cervical/Uterine Cancer Patients
Conditions: Head and Neck Cancer;   Melanoma;   Breast Cancer;   Cervical Cancer;   Uterine Cancer
Intervention: Drug: fluorescent cRGDY-PEG-Cy5.5-C dots
5 Recruiting Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
Conditions: Uterine Neoplasms;   Endometrial Neoplasms
Intervention:
6 Not yet recruiting Sentinel Node Mapping in Women With Cervical and Endometrial Cancer
Conditions: Uterine Cervical Neoplasms;   Uterine Neoplasms
Intervention: Procedure: Sentinel lymph node mapping
7 Not yet recruiting Sentinel Node Mapping in Women With High Risk Endometrial Cancer and Cervical Cancer
Conditions: Uterine Cervical Neoplasms;   Uterine Neoplasms
Intervention: Procedure: SLN mapping and removal of PET-positive lymph nodes
8 Recruiting Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen
Conditions: Breast Cancer;   Ovarian Cancer;   Cancer of the Uterus
Interventions: Drug: GDC-0032;   Drug: Tamoxifen
9 Recruiting A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus
Condition: Endometrial Cancer
Intervention: Drug: Carboplatin AUC and Abraxane 100mg/m2
10 Recruiting Cancer of the Uterus and Treatment of Stress Urinary Incontinence
Conditions: Endometrial Cancer;   Stress Urinary Incontinence
Intervention:
11 Recruiting Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Conditions: Breast Carcinoma;   Endometrial Clear Cell Adenocarcinoma;   Endometrial Serous Adenocarcinoma;   Uterine Corpus Cancer;   Uterine Corpus Carcinosarcoma
Interventions: Drug: Metformin Hydrochloride;   Drug: Doxycycline
12 Recruiting A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping
Conditions: Endometrial Cancer;   Uterine Cancer;   Cervical Cancer
Intervention: Device: PINPOINT
13 Recruiting Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors
Conditions: Cervical Cancer;   Uterine Cancer;   Ovarian Cancer
Intervention: Device: PAMS I
14 Recruiting Assisted Exercise in Obese Endometrial Cancer Patients
Conditions: Stage I Endometrial Adenocarcinoma;   Uterine Cancer;   Obesity
Interventions: Behavioral: Exercise on stationary recumbent exercise cycle;   Behavioral: Health Education;   Behavioral: Questionnaires;   Procedure: Neuroimaging;   Procedure: Genetic and Biomarkers
15 Recruiting Biobehavioral Intervention in Gynecologic Oncology Patients
Conditions: Neoplasms;   Ovarian Neoplasms;   Uterine Neoplasms;   Vulva
Intervention: Behavioral: BBI intervention
16 Not yet recruiting Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
Conditions: Endometrial Serous Adenocarcinoma;   Stage I Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Stage III Uterine Corpus Cancer;   Stage IV Uterine Corpus Cancer
Interventions: Other: Diagnostic Laboratory Biomarker Analysis;   Other: Immunohistochemistry Staining Method;   Other: Medical Chart Review;   Genetic: Microarray Analysis;   Other: Study of Socioeconomic and Demographic Variables;   Genetic: Western Blotting
17 Recruiting Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer
Conditions: Endometrial Serous Adenocarcinoma;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC1 Uterine Corpus Cancer;   Stage IIIC2 Uterine Corpus Cancer;   Stage IVA Uterine Corpus Cancer;   Stage IVB Uterine Corpus Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: 3-Dimensional Conformal Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis
18 Recruiting Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
Conditions: Ovarian Cancer;   Cervical Cancer;   Uterine Cancer;   Anemia
Interventions: Other: Oral Ferrous Fumarate;   Other: Placebo
19 Recruiting A Mind-body Intervention to Improve Body and/or Self Image
Conditions: Breast Cancer;   Ovarian Cancer;   Uterine Cancer;   Cervical Cancer
Interventions: Behavioral: Hypnotic Relaxation Therapy;   Behavioral: Progressive Muscle Relaxation
20 Recruiting Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
Conditions: Stage IA Uterine Sarcoma;   Stage IB Uterine Sarcoma;   Stage IC Uterine Sarcoma;   Stage IIA Uterine Sarcoma;   Stage IIB Uterine Sarcoma;   Stage IIIA Uterine Sarcoma;   Stage IIIB Uterine Sarcoma;   Stage IIIC Uterine Sarcoma;   Stage IVA Uterine Sarcoma;   Stage IVB Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Radiation: external beam radiation therapy;   Radiation: brachytherapy;   Radiation: intensity-modulated radiation therapy;   Other: laboratory biomarker analysis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.